The Food and Drug Administration’s approval of a generic version of mifepristone, a drug used in chemical abortions, isn’t just another bureaucratic misstep. It’s a profound betrayal of pro-life Americans and a reckless disregard for public safety.

The agency has now accelerated the mass production of a drug that ends unborn lives and carries serious risks for women. In doing so, the FDA’s bureaucracy has made clear that it serves ideological interests, not the citizens or the administration it is supposed to answer to.

Every life matters — both the woman and the child. Without moral clarity in policy, America risks losing its foundation altogether.

Only days before the approval, FDA Commissioner Marty Makary publicly pledged to conduct a full safety review of mifepristone. That commi

See Full Page